Circulating Resistin Is Associated with Plasma Glucagon-Like Peptide-1 in Cirrhotic Patients with Hepatitis C Virus Genotype-4 Infection

References

• Hoofnagle JH. Course and outcome of hepatitis C. Hepatology. 2002;36:21–29.
   PubMed Web of Science ®Google Scholar
• Sievert W, Altraif I, Razavi HA, et al. Systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt. Liver Int. 2011;31:61–80. doi:10.1111/j.1478-3231.2011.02540.x.
   PubMed Web of Science ®Google Scholar
• Moucari R, Asselah T, Cazals-Hatem D, et al. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis. Gastroenterology. 2008;13:416–423. doi:10.1053/j.gastro.2007.11.010.
   Web of Science ®Google Scholar
• Duseja A, Dhiman RK, Chawla Y, et al. Insulin resistance is common in patients with predominantly genotype 3 chronic hepatitis C. Dig Dis Sci. 2009;54:1778–1782. doi:10.1007/s10620-009-0844-y.
   PubMed Web of Science ®Google Scholar
• Hung CH, Lee CM, Lu SN. Hepatitis C virus-associated insulin resistance: pathogenicmechanisms and clinical implications. Expert Rev Anti Infect Ther. 2011;9:525–533. doi:10.1586/eri.11.33.
   PubMed Web of Science ®Google Scholar
• D’Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44:217–231. doi:10.1016/j.jhep.2005.10.013.
   PubMed Web of Science ®Google Scholar
• Tilg H, Wilmer A, Vogel W, et al. Serum levels of cytokines in chronic liver diseases. Gastroenterology. 1992;103:264–274.
   PubMed Web of Science ®Google Scholar
• Calzadilla-Bertot L, Vilar-Gomez E, Torres-Gonzalez A, et al. Impaired glucose metabolism increases risk of hepatic decompensation and death in patients with compensated hepatitis C virus-related cirrhosis. Dig Liver Dis. 2016;48:283–290. doi:10.1016/j.dld.2015.12.002.
   PubMedGoogle Scholar
• Bertolani C, Sancho-Bru P, Failli P, et al. Resistin as an intrahepatic cytokine: overexpression during chronic injury and induction of proinflammatory actions in hepatic stellate cells. Am J Pathol. 2006;169:2042–2053. doi:10.2353/ajpath.2006.060081.
   PubMed Web of Science ®Google Scholar
• Kakizaki S, Sohara N, Yamazaki Y, et al. Elevated plasma resistin concentrations in patients with liver cirrhosis. J Gastroenterol Hepatol. 2008;23:73–77. doi:10.1111/j.1440-1746.2006.04757.x.
   PubMed Web of Science ®Google Scholar
• Yagmur E, Trautwein C, Gressner AM, Tacke F. Resistin serum levels are associated with insulin resistance, disease severity, clinical complications, and prognosis in patients with chronic liver diseases. Am J Gastroenterol. 2006;101:1244–1252. doi:10.1111/j.1572-0241.2006.00543.x.
   PubMed Web of Science ®Google Scholar
• Silva TE, Costa-Silva M, Correa CG, et al. Clinical significance of serum adiponectin and resistin levels in liver cirrhosis. Ann Hepatol. 2018;17:286–299. doi:10.5604/01.3001.0010.8660.
   PubMed Web of Science ®Google Scholar
• Pagano C, Soardo G, Pilon C, et al. Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance. J Clin Endocrinol Metab. 2006;91:1081–1086. doi:10.1210/jc.2005-1056.
   PubMed Web of Science ®Google Scholar
• Cho YM, Fujita Y, Kieffer TJ. Glucagon-like peptide-1: glucose homeostasis and beyond. Annu Rev Physiol. 2014;76:535–559. doi:10.1146/annurev-physiol-021113-170315.
   PubMed Web of Science ®Google Scholar
• Itou M, Oriishi T, Taniguchi E, Kawaguchi T, Ueno T, Sata M. A gut hormone, glucagon-like peptide-1, associated with HCV-induced insulin resistance. J Hepatol. 2005;42:81–82. Conference poster. doi:10.1016/S0168-8278(05)81621-6.
   Web of Science ®Google Scholar
• Kruszynska YT, Ghatei MA, Bloom SR, McIntyre N. Insulin secretion and plasma levels of glucose-dependent insulinotropic peptide and glucagon-like peptide 1 [7-36 amide] after oral glucose in cirrhosis. Hepatology. 1995;21:933–941.
   PubMed Web of Science ®Google Scholar
• Junker AE. The role of incretin hormones and glucagon in patients with liver disease. Dan Med J. 2017;64:B53–63.
   Web of Science ®Google Scholar
• Itou M, Kawaguchi T, Taniguchi EI, et al. Altered expression of glucagon-like peptide −1 and dipeptidyl peptidase IV in patients with HCV-related glucose intolerance. J Gastroenterol Hepatol. 2008;23:244–251. doi:10.1111/j.1440-1746.2007.05183.x.
   PubMed Web of Science ®Google Scholar
• Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of oesophagus or bleeding oesophageal varices. Br J Surg. 1973;60:646–649.
   PubMed Web of Science ®Google Scholar
• Mendenhall CL. Protein-calorie malnutrition in alcoholic liver disease. In: Watson RR, Watzl B, eds. Nutrition and Alcohol. Boca Raton, FL: CRC Press; 1992:363–384.
   Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419.
   PubMed Web of Science ®Google Scholar
• Kamal S, Nassar I. Hepatitis C genotype 4: what we know and what we don’t yet know. Hepatology. 2008;47:1371–1383. doi:10.1002/hep.22127.
   PubMed Web of Science ®Google Scholar
• Egyptian Ministry of Health: Egyptian Ministry of Health Annual Report. 2007.
   Google Scholar
• Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology. 2007;132:2131–2157. doi:10.1053/j.gastro.2007.03.054.
   PubMed Web of Science ®Google Scholar
• Yamaoka-Tojo M, Tojo T, Takahira N, et al. Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular disease. Cardiovasc Diabetol. 2010;9:17. doi:10.1186/1475-2840-9-17.
   PubMed Web of Science ®Google Scholar
• Kahles F, Meyer C, Möllmann J, et al. GLP-1 secretion is increased by inflammatory stimuli in an IL-6-dependent manner, leading to hyperinsulinemia and blood glucose lowering. Diabetes. 2014;63:3221–3229. doi:10.2337/db14-0100.
   PubMed Web of Science ®Google Scholar
• Piotrowski K, Becker M, Zugwurst J, et al. Circulating concentrations of GLP-1 are associated with coronary atherosclerosis in humans. Cardiovasc Diabetol. 2013;12:117. doi:10.1186/1475-2840-12-117.
   PubMed Web of Science ®Google Scholar
• Helal TESA, Ehsan NA, Radwan NA, Abdelsameea E. Relationship between hepatic progenitor cells and stellate cells in chronic hepatitis C genotype-4. Apmis. 2018;126:14–20. doi:10.1111/apm.12787.
   PubMed Web of Science ®Google Scholar
• Falkowski O, An HJ, Ianus IA, et al. Regeneration of hepatocyte ‘buds’ in cirrhosis from intrabiliary stem cells. J Hepatol. 2003;39:357–364.
   PubMed Web of Science ®Google Scholar
• Nobili V, Carpino G, Alisi A, et al. Hepatic progenitor cells activation, fibrosis and adipokines production in pediatric nonalcoholic fatty liver disease. Hepatology. 2012;56:2142–2153. doi:10.1002/hep.25742.
   PubMed Web of Science ®Google Scholar
• Nolte W, Hartmann H, Ramadori G. Glucose metabolism and liver cirrhosis. Exp Clin Endocrinol Diabetes. 1995;103:63–74. doi:10.1055/s-0029-1211331.
   PubMed Web of Science ®Google Scholar
• Junker AE, Gluud LL, Holst JJ, Knop FK, Vilsbøll T. Influence of gastrointestinal factors on glucose metabolism in patients with cirrhosis. J Gastroenterol Hepatol. 2015;30:1522–1528. doi:10.1111/jgh.12981.
   PubMed Web of Science ®Google Scholar
• Aulinger BA, Vahl TP, Wilson-Pérez HE, Prigeon RL, D’Alessio DA. β-cell sensitivity to GLP-1 in healthy humans is variable and proportional to insulin sensitivity. J Clin Endocrinol Metab. 2015;100:2489–2496. doi:10.1210/jc.2014-4009.
   PubMed Web of Science ®Google Scholar
• Bahr MJ, Ockenga J, Boker KH, Manns MP, Tietge UJ. Elevated resistin levels in cirrhosis are associated with the proinflammatory state and altered hepatic glucose metabolism but not with insulin resistance. Am J Physiol Endocrinol Metab. 2006;291:E199–E206. doi:10.1152/ajpendo.00359.2005.
   PubMed Web of Science ®Google Scholar
• Kalafateli M, Triantos C, Tsochatzis E, et al. Adipokines levels are associated with the severity of liver disease in patients with alcoholic cirrhosis. World J Gastroenterol. 2015;2:3020–3029. doi:10.3748/wjg.v21.i10.3020.
   Web of Science ®Google Scholar
• Singla P, Bardoloi A, Parkash A. Metabolic effects of obesity: a review. World J Diabetes. 2010;1:76–88. doi:10.4239/wjd.v1.i3.76.
   PubMedGoogle Scholar
• Steppan CM, Wang J, Whiteman EL, Birnbaum MJ, Lazar MA. Activation of SOCS-3 by resistin. Mol Cell Biol. 2005;25:1569–1575. doi:10.1128/MCB.25.4.1569-1575.2005.
   PubMed Web of Science ®Google Scholar